Vol 72, No 1 (2022)

Date published: 2022-02-09

Table of Contents

open access

Original article

Serum ROBO4 and CLEC14A: preliminary evaluation as diagnostic and progression biomarkers in colorectal cancer patients

Łukasz Pietrzyk, Kamil Torres

Research paper (original)

Nowotwory. Journal of Oncology 2022;72(1):1-10.

Prognostic significance of sex in patients with primary tracheal tumors – a retrospective, single-center study

Aleksandra Piórek, Adam Płużański, Dariusz Mirosław Kowalski, Maciej Krzakowski

Research paper (original)

Nowotwory. Journal of Oncology 2022;72(1):11-15.

Radiation dose in CT-guided microwave liver tumor ablation

Grzegorz Rosiak, Joanna Podgórska, Katarzyna Pasicz, Krzysztof Milczarek, Dariusz Konecki, Olgierd Rowinski

Research paper (original)

Nowotwory. Journal of Oncology 2022;72(1):16-19.

Secondary prevention and treatment of cervical cancer – an update from Poland

Patryk Poniewierza, Marcin Śniadecki, Michał Brzeziński, Dagmara Klasa-Mazurkiewicz, Grzegorz Panek

Research paper (original)

Nowotwory. Journal of Oncology 2022;72(1):20-25.
Review article

Off-label use of medicinal products in oncology: exercising due diligence or experimental activity?

Justyna Estera Król-Całkowska, Janusz Jaroszyński

Review paper

Nowotwory. Journal of Oncology 2022;72(1):26-33.

The Poly(ADP-ribose) polymerase inhibitors in pancreatic cancer

Katarzyna Zubik, Julia Talaśka, Dawid Sigorski, Sergiusz Nawrocki

Review paper

Nowotwory. Journal of Oncology 2022;72(1):34-43.
Guidelines and recommendations

Consensus on methods of development of clinical practice guidelines in oncology under the auspices of Maria Sklodowska-Curie National Research Institute of Oncology and the Agency for Health Technology Assessment and Tariff System

Jan Walewski, Dominik Dziurda, Mariusz Bidziński, Barbara Bobek-Bilewicz, Marek Dedecjus, Iwona Hus, Beata Jagielska, Jacek Jassem, Andrzej Kawecki, Dariusz Kowalski, Magdalena Krasztel, Maciej Krzakowski, Tomasz Kubiatowski, Piotr Potemski, Radosław Mądry, Piotr Rutkowski, Anna Rychert, Janusz Ryś, Krzysztof Składowski, Rafał Tarnawski, Hanna Tchórzewska-Korba, Andrzej Tysarowski, Piotr J. Wysocki, Roman Topór-Mądry

Guidelines / Expert consensus

Nowotwory. Journal of Oncology 2022;72(1):44-50.
Pictures in oncology

Melanoma metastases to the intestines – presentation and management

Michał Aporowicz, Adam Maciejczyk, Rafał Matkowski, Marcin Ziętek

Pictures in Oncology

Nowotwory. Journal of Oncology 2022;72(1):51.
Oncogeriatrics

Hepatocellular cancer and colorectal liver metastasis treatment in the older population

Jakub Kenig

Review paper

Nowotwory. Journal of Oncology 2022;72(1):52-57.
Genetics and oncology

Phacomatoses, genetic testing for personalisation of clinical management (part 2)

Anna Kofla-Dłubacz, Andrzej Stawarski, Tomasz Pytrus, Justyna Gil

Review paper

Nowotwory. Journal of Oncology 2022;72(1):58-64.
Letter to the Editor

Is the elimination of cervical cancer now 3 times easier? One-dose vaccine efficacy has far-reaching implications

Paweł Koczkodaj, Joakim Dillner, Marta Manczuk

Letter to the Editor

Nowotwory. Journal of Oncology 2022;72(1):65-66.



Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl